ALI FARAZ (Chief Executive Officer) received a stock award from TENAYA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/5/2026ACC: 0001193125-26-039760
DirectorOfficer· Chief Executive Officer
Since Jul 2021
+1.11M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.11M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+158.60K
Price / share
—
Trade value
—
% of position
52.9%
2/3/2026
299.67K→458.27K
Total
Net shares
+158.60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2026 | A · Award | +158.60K | — | — | 52.9% | 299.67K | 458.27K |
| Total | +158.60K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to buy)
Direct
Converts to
Common Stock
952.25K shares
Shares
+952.25K
Strike price
0.915
Held after
952.25K
Exercisable
—
2/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Direct | Common Stock952.25K shares | 2/3/2026 | A · Award | +952.25K | 0.915 | — | 952.25K |